Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Nils Von Hentig"'
Publikováno v:
Southern African Journal of HIV Medicine, Vol 22, Iss 1, Pp e1-e3 (2021)
No abstract available.
Externí odkaz:
https://doaj.org/article/93bf507fcad14537b9fc417996462050
Autor:
Timo Wolf, Christoph Stephan, Gerrit Kann, Junaid Owasil, Karina Kuczka, Annette Haberl, Nils von Hentig, Sebastian Harder, Pavel Khaykin
Publikováno v:
HIV/AIDS (Auckland, N.Z.)
Gerrit Kann,1,* Junaid Owasil,1,* Karina Kuczka,2 Annette Haberl,1 Timo Wolf,1 Pavel Khaykin,1 Sebastian Harder,2 Christoph Stephan,1 Nils von Hentig1 1HIVCENTER, Medical HIV Treatment and Research Unit, Johann Wolfgang Goethe University Fran
Autor:
Klitsunova Yuliia Aleksandrovna, Lucrecia María Curto, Annada Prasad Mohapatra, C. R. Harisha, Ramar Krishnamurthy, J. C. ugwu, Adriana Carlucci, Bijay Kumar Sahoo, Sukumar Patil, P. C. Ojeli, W. Jessie Suneetha, Akanni E. Olufemi, Nikita Patel, Ogunlade A. Adebola, Sanni O. Bilikis, Ostapenko Andrii Alekseevich, S. C. Chaturvedi, Swetal Patel, Olaniran O. Isiaka, A. B. Thakar, Adejumo M. Temitope, Maira Huerta Reyes, Ivaschuk Viktoriia Aleksandrovna, María Lourdes Puig San Andrés, Kulbachuk Aleksandr Sergeevich, A. A. Abdul Rahaman, Chioma Assumpta Anosike, Nils Von Hentig, Aruna Samant, Iyiola O. Abdulmajid, V. J. Shukla, Ivahnenko Nataliia Timofeevna, Aparna Saraf, Arturo Aguilar-Rojas, Akinbo B. David, B. Anila Kumari, Masheer Ahmed Khan, S. C. Abugu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf7cfc48e83277180176520dac781917
https://doi.org/10.9734/bpi/tprd/v5
https://doi.org/10.9734/bpi/tprd/v5
Autor:
Peter Kotzerke, Christoph Stephan, Martin Stürmer, Markus Bickel, Pavel Khaykin, Michael Kurowski, Nils von Hentig, Reinhard Brodt, Gabi Nisius, Annette Haberl
Publikováno v:
Therapeutic Drug Monitoring. 36:192-201
Objective Lopinavir/ritonavir plus nucleoside reverse transcriptase inhibitors is one standard antiretroviral therapy regimen, both in patients with HIV alone and coinfected with hepatitis B or C. Our objective was to investigate whether hepatitis co
Autor:
Nils von Hentig
Publikováno v:
Journal of Antivirals & Antiretrovirals.
Autor:
Valentin Bartha, G Knecht, Peter Gute, Nils von Hentig, Pavel Khaykin, H. R. Brodt, Christoph Stephan, Markus Bickel, Annemarie Berger, Martin Stürmer, Eva Herrmann
Publikováno v:
Medical Microbiology and Immunology. 202:117-124
To explore CD4-cell and viral evolution in relation to different levels of HIV-1 replication, as observed during protease inhibitor (PI)-based antiretroviral therapy. Adult HIV-1 infected cohort patients, receiving historical salvage therapy with dai
Autor:
Regina Allwinn, Markus Bickel, Annette Haberl, Imke Wieters, Nils von Hentig, Hans Reinhard Brodt, Christoph Stephan, Pavel Khaykin, Gabi Nisius, Hans W. Doerr, Eva Herrmann
Publikováno v:
Clinical Infectious Diseases. 52:122-127
BACKGROUND To determine the rate of seroconversion after 2 doses of a novel split virion, inactivated, adjuvanted pandemic H1N1 influenza vaccine (A/California/7/2009) in human immunodeficiency virus type 1 (HIV-1)-infected patients (ClinicalTrials.g
Autor:
Nils von Hentig, Hans Reinhard Brodt, Eva Herrmann, Gabi Nisius, Regina Allwinn, Pavel Khaykin, Markus Bickel, Hans W. Doerr, Annette Haberl, Imke Wieters, Christoph Stephan
Publikováno v:
AIDS. 24:F31-F35
OBJECTIVE To determine rates of seroconversion after single vaccination with a novel split virion, inactivated, adjuvanted pandemic H1N1 influenza vaccine (A/California/7/2009) in HIV-1-infected patients (ClinicalTrials.gov Identifier: NCT01017172).
Autor:
Thomas A. Lutz, Wolf O. Bechstein, Nils von Hentig, Johannes Kuetscher, Evrim Anadol, Jürgen K. Rockstroh, Markus Bickel, Hans Reinhard Brodt, Wolf Peter Hofmann, Martin Vogel, C. Moench, Michael Kurowski, Tessa Lennemann
Publikováno v:
Journal of Antimicrobial Chemotherapy. 65:999-1004
The number of HIV-infected patients receiving orthotopic liver transplantation (OLTX) is increasing. One major challenge is the severe drug-drug interactions between immunosuppressive drugs such as tacrolimus and ritonavir-boosted HIV-1 protease inhi